<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08059020201845</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,8% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6100</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:16:30.879Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201838</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,8% 1 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6099</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:16:24.889Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201821</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,1% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6096</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:16:23.685Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201630</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,1% 1 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6095</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:16:22.470Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201524</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>EasyGo 1.8% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6067</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:16:02.066Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201517</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,8% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6102</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:56.102Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201500</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,8% 1 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6101</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:54.863Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201494</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,1% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6098</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:53.659Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201487</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,1% 1 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6097</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:52.461Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201470</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,8% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6092</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:46.449Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201463</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,8% 1 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6091</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:45.257Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201456</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,1% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6094</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:44.057Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020201449</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,1% 1 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6093</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:39.258Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020200305</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,8% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6066</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:27.249Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020200299</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,1% 1 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6053</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:26.043Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020200282</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,1% 2 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6054</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:20.034Z</lastUpdated>
  </row>
  <row>
    <udiDi>08059020200275</udiDi>
    <basicUdiDi>805902020FILLERHC4</basicUdiDi>
    <tradeName>Diart 1,8% 1 ml</tradeName>
    <deviceName>Diart</deviceName>
    <manufacturerName>Diaco Biofarmaceutici srl</manufacturerName>
    <manufacturerSrn>IT-MF-000012117</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6055</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:15:18.850Z</lastUpdated>
  </row>
</eudamedExport>